HK1022715A1 - Fusion proteins containing stress proteins for inducing immune responses - Google Patents
Fusion proteins containing stress proteins for inducing immune responsesInfo
- Publication number
- HK1022715A1 HK1022715A1 HK00101484A HK00101484A HK1022715A1 HK 1022715 A1 HK1022715 A1 HK 1022715A1 HK 00101484 A HK00101484 A HK 00101484A HK 00101484 A HK00101484 A HK 00101484A HK 1022715 A1 HK1022715 A1 HK 1022715A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antigen
- relates
- vaccines
- immune responses
- stress protein
- Prior art date
Links
- 102000002812 Heat-Shock Proteins Human genes 0.000 title abstract 7
- 108010004889 Heat-Shock Proteins Proteins 0.000 title abstract 7
- 230000028993 immune response Effects 0.000 title abstract 5
- 230000001939 inductive effect Effects 0.000 title abstract 3
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 7
- 102000036639 antigens Human genes 0.000 abstract 7
- 108091007433 antigens Proteins 0.000 abstract 7
- 229960005486 vaccine Drugs 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000013566 allergen Substances 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 230000004044 response Effects 0.000 abstract 2
- 241000712461 unidentified influenza virus Species 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75662196A | 1996-11-26 | 1996-11-26 | |
| PCT/CA1997/000897 WO1998023735A1 (en) | 1996-11-26 | 1997-11-25 | Immune responses using compositions containing stress proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1022715A1 true HK1022715A1 (en) | 2000-08-18 |
Family
ID=25044309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00101484A HK1022715A1 (en) | 1996-11-26 | 2000-03-10 | Fusion proteins containing stress proteins for inducing immune responses |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0941315B1 (pt) |
| JP (2) | JP4484969B2 (pt) |
| AT (1) | ATE318899T1 (pt) |
| AU (1) | AU736318B2 (pt) |
| CA (1) | CA2272536A1 (pt) |
| DE (1) | DE69735376T2 (pt) |
| DK (1) | DK0941315T3 (pt) |
| ES (1) | ES2258796T3 (pt) |
| HK (1) | HK1022715A1 (pt) |
| PT (1) | PT941315E (pt) |
| WO (1) | WO1998023735A1 (pt) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT700445E (pt) | 1993-06-04 | 2002-07-31 | Whitehead Biomedical Inst | Proteinas de stress e suas utilizacoes |
| CA2229543A1 (en) | 1995-08-18 | 1997-02-27 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| US6761892B1 (en) | 1995-08-18 | 2004-07-13 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| US6709672B2 (en) | 1997-03-05 | 2004-03-23 | Biotech Tools S.A. | Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction |
| BE1011033A6 (fr) * | 1997-03-05 | 1999-04-06 | Univ Bruxelles | Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer. |
| KR20060111731A (ko) | 1997-08-05 | 2006-10-27 | 스트레스젠 바이오테크놀러지스 코포레이션 | 사람 유두종 바이러스 항원과 스트레스 단백질을 포함하는융합 단백질을 포함하는 조성물에 의해 유도된 사람 유두종바이러스 항원에 대한 면역 반응 |
| CA2297786C (en) | 1997-08-05 | 2011-06-14 | Vlaams Interuniversitair Instituut Voor Biotechnologie | New immunoprotective influenza antigen and its use in vaccination |
| US7731972B1 (en) | 2000-02-04 | 2010-06-08 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Immunoprotective influenza antigen and its use in vaccination |
| US6007821A (en) * | 1997-10-16 | 1999-12-28 | Fordham University | Method and compositions for the treatment of autoimmune disease using heat shock proteins |
| EP1049483A1 (en) * | 1998-01-23 | 2000-11-08 | National Jewish Medical and Research Center | Method for treating inflammatory diseases using heat shock proteins |
| EP1054683B1 (en) | 1998-02-20 | 2007-04-11 | University Of Miami | Modified heat shock protein-antigenic peptide complex |
| DE69941156D1 (de) * | 1998-11-24 | 2009-09-03 | Bristol Myers Squibb Co | Intranukleärer, gerichteter transport von verbindungen durch das 70kd-hitzeschockprotein |
| EP1196772A2 (en) | 1999-07-08 | 2002-04-17 | Stressgen Biotechnologies Corporation | Induction of a th1-like response in vitro |
| AUPQ233799A0 (en) * | 1999-08-19 | 1999-09-09 | Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales | Recombinant sub-unit vaccine |
| US7378096B2 (en) | 1999-09-30 | 2008-05-27 | Health Research, Inc. | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| US20020039583A1 (en) * | 1999-09-30 | 2002-04-04 | Subjeck John R. | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| JP2003510334A (ja) * | 1999-09-30 | 2003-03-18 | コリクサ コーポレイション | 癌及び感染症の予防及び治療のためのストレスタンパク質組成物及び方法 |
| US8128922B2 (en) | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| DE60038622D1 (de) * | 1999-10-20 | 2008-05-29 | Univ Johns Hopkins Med | Chimäre immunogene zusammensetzungen und dafür kodierende nukleinsäure |
| US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| JP2003519668A (ja) | 2000-01-14 | 2003-06-24 | ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ | 熱ショックタンパク質融合タンパク質による、ｃｄ４＋ｔ細胞非依存性のインビボｃｔｌ惹起による個別ａｔｐ結合ドメインのマッピング |
| DK1296711T3 (da) | 2000-06-26 | 2006-08-28 | Stressgen Biotechnologies Corp | HPV-E7 til behandling af humant papillomavirus |
| AU2001278117A1 (en) | 2000-08-03 | 2002-02-18 | Johns Hopkins University | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| WO2002062959A2 (en) | 2001-02-05 | 2002-08-15 | Stressgen Biotechnologies Corp. | Hepatitis b virus treatment |
| DK1536006T3 (da) | 2002-08-30 | 2011-10-17 | Medinet Co Ltd | Cancerantigener og anvendelse deraf |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| US7420037B2 (en) | 2003-02-13 | 2008-09-02 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
| US7309491B2 (en) | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
| WO2004098526A2 (en) | 2003-05-05 | 2004-11-18 | Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| AU2005322960A1 (en) | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines |
| BRPI0606479A (pt) | 2005-01-19 | 2008-03-11 | Vaxinnate Corp | composições; proteìnas de fusão; polipepitìdeos; e métodos para estimular uma resposta imune em um indivìduo |
| ATE552846T1 (de) | 2005-12-06 | 2012-04-15 | Yeda Res & Dev | Verbesserter grippeimpfstoff |
| EP1991264B1 (en) | 2006-03-07 | 2015-01-07 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| WO2008054535A2 (en) * | 2006-05-11 | 2008-05-08 | Novavax, Inc. | Novel influenza m2 vaccines |
| WO2008094197A2 (en) | 2006-07-27 | 2008-08-07 | Ligocyte Pharmaceuticals, Inc. | Chimeric influenza virus-like particles |
| JP2009544322A (ja) * | 2006-07-27 | 2009-12-17 | リゴサイト ファーマシューティカルズ インコーポレイテッド | キメラウイルス様粒子 |
| WO2008118587A2 (en) * | 2007-02-23 | 2008-10-02 | Baylor Research Institute | Therapeutic applications of activation of human antigen-presenting cells through dectin-1 |
| US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
| DK2257301T3 (da) | 2008-03-03 | 2014-04-28 | Univ Miami | Immunterapi baseret på allogene cancerceller. |
| WO2009117116A2 (en) | 2008-03-20 | 2009-09-24 | University Of Miami | Heat shock protein gp96 vaccination and methods of using same |
| JP5917402B2 (ja) | 2009-11-03 | 2016-05-11 | タケダ ヴァクシーンズ， インコーポレイテッド | キメラＲＳＶ−Ｆポリペプチド、およびレンチウイルスＧａｇまたはアルファレトロウイルスＧａｇに基づくＶＬＰ |
| US8685406B2 (en) | 2009-11-13 | 2014-04-01 | The Board Of Regents Of The University Of Texas System | Compositions of and method of using heat shock protein peptides |
| US20140255449A1 (en) * | 2011-07-21 | 2014-09-11 | Biotech Tools S.A. | Dosage of dnak |
| ES2845727T3 (es) | 2015-02-06 | 2021-07-27 | Heat Biologics Inc | Vector que coexpresa una vacuna y moléculas coestimuladoras |
| CA3040123A1 (en) | 2016-10-11 | 2018-04-19 | University Of Miami | Vectors and vaccine cells for immunity against zika virus |
| US11548930B2 (en) | 2017-04-04 | 2023-01-10 | Heat Biologics, Inc. | Intratumoral vaccination |
| KR101805430B1 (ko) | 2017-04-26 | 2017-12-06 | (주)넥스젠바이오텍 | 항산화 활성 및 피부 세포 증식 효과가 증가한 열 충격 단백질의 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 |
| CN118076389A (zh) * | 2021-08-30 | 2024-05-24 | 日环科学株式会社 | 免疫赋活制剂及含有该免疫赋活制剂的化妆品、食品、饲料添加剂、准药品 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102687A (en) * | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
| PT700445E (pt) * | 1993-06-04 | 2002-07-31 | Whitehead Biomedical Inst | Proteinas de stress e suas utilizacoes |
| US5961979A (en) * | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
| CA2229543A1 (en) * | 1995-08-18 | 1997-02-27 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| WO1997026910A2 (de) * | 1996-01-27 | 1997-07-31 | Max-Delbrück-Centrum für Molekulare Medizin | Tumorimpfstoff für die immuntherapie von malignen tumoren |
-
1997
- 1997-11-25 CA CA002272536A patent/CA2272536A1/en not_active Abandoned
- 1997-11-25 AU AU51120/98A patent/AU736318B2/en not_active Ceased
- 1997-11-25 DE DE69735376T patent/DE69735376T2/de not_active Expired - Lifetime
- 1997-11-25 JP JP52408198A patent/JP4484969B2/ja not_active Expired - Fee Related
- 1997-11-25 EP EP97945684A patent/EP0941315B1/en not_active Expired - Lifetime
- 1997-11-25 WO PCT/CA1997/000897 patent/WO1998023735A1/en active IP Right Grant
- 1997-11-25 DK DK97945684T patent/DK0941315T3/da active
- 1997-11-25 ES ES97945684T patent/ES2258796T3/es not_active Expired - Lifetime
- 1997-11-25 PT PT97945684T patent/PT941315E/pt unknown
- 1997-11-25 AT AT97945684T patent/ATE318899T1/de not_active IP Right Cessation
-
2000
- 2000-03-10 HK HK00101484A patent/HK1022715A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 JP JP2008122787A patent/JP2008214360A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP4484969B2 (ja) | 2010-06-16 |
| WO1998023735A1 (en) | 1998-06-04 |
| DE69735376T2 (de) | 2006-12-14 |
| CA2272536A1 (en) | 1998-06-04 |
| EP0941315A1 (en) | 1999-09-15 |
| EP0941315B1 (en) | 2006-03-01 |
| ATE318899T1 (de) | 2006-03-15 |
| JP2008214360A (ja) | 2008-09-18 |
| PT941315E (pt) | 2006-06-30 |
| AU5112098A (en) | 1998-06-22 |
| DK0941315T3 (da) | 2006-05-15 |
| AU736318B2 (en) | 2001-07-26 |
| ES2258796T3 (es) | 2006-09-01 |
| JP2001504702A (ja) | 2001-04-10 |
| DE69735376D1 (de) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1022715A1 (en) | Fusion proteins containing stress proteins for inducing immune responses | |
| DK0587780T3 (da) | Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt | |
| EP2311952A3 (en) | Antibodies to MRT-1 protein or fragments thereof | |
| WO1995029193A3 (en) | Melanoma antigens | |
| HUP0003601A2 (hu) | HPV elleni immunválaszok kiváltása HPV-antigént és stresszproteint, vagy ezen proteineket expresszálni képes expressziós vektort tartalmazó készítményekkel | |
| ATE468127T1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| WO2007016185A3 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| DE60121136D1 (de) | Proteasom-influenzavirus-impfstoffzusammensetzung | |
| EP2290091A3 (en) | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions | |
| BR9907883A (pt) | Composição de vacina, processo para eliciar uma resposta imune a um antìgeno de vìrus de herpes simplex, e, composição imunogênica | |
| ATE389397T1 (de) | Adjuvante zusammensetzungen | |
| EP4226938A3 (en) | Coronavirus vaccine | |
| WO2005000884A8 (en) | Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli | |
| WO2023147092A3 (en) | Coronavirus vaccine | |
| ATE287957T1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
| WO2004078099A3 (en) | Compositions and methods for the generation of protective immune response against malaria | |
| WO2006110915A3 (en) | Vaccine formulations for leishmania | |
| ES2110996T3 (es) | Alergeno de polen de ballico. | |
| WO2001074845A3 (en) | Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof | |
| ATE448793T1 (de) | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens | |
| DE69739233D1 (de) | Ein durch labile bindung an einen träger gebundenes antigen enthaltender impstoff | |
| DE60131975D1 (de) | Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten | |
| US8404243B2 (en) | Peptide adjuvants | |
| WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091125 |